论文部分内容阅读
为了解聚合人血清白蛋白受体(PHSA.R)在乙型肝炎中的作用及影响,我们对686例乙型肝炎患者进行了PHSA.R、HBVDNA、HBeAg、抗HBe的检测,现将结果报告如下。 1 临床资料 1.1 病例选择 686例乙型肝炎患者均系1996年1月～1998年6月间住院患者,男581例,女105例,年龄18～63岁,平均32.6岁,均按1995年北京第5次全国传染病寄生虫病学术会议修改的《病毒性肝炎防治方案》标准选择病例,其中急性乙型肝炎(AH)38例,慢性乙型肝炎轻度(CHBⅠ)188例,慢性乙型肝炎中度(CHBⅡ)180例,慢性乙型肝炎重度(CHB
To understand the role and influence of aggregated human serum albumin receptor (PHSA.R) in hepatitis B, 686 hepatitis B patients were tested for PHSA.R, HBVDNA, HBeAg and anti-HBe. The results The report is as follows. 1 Clinical data 1.1 Case Selection 686 cases of hepatitis B patients were hospitalized from January 1996 to June 1998, 581 were male and female 105 cases, aged 18 to 63 years, mean 32.6 years, according to 1995 Beijing The 5th National Program of Infectious Diseases Parasitic Diseases, “Virus Hepatitis Control Program” standard selection of cases, including acute hepatitis B (AH) in 38 cases, mild chronic hepatitis B (CHB Ⅰ) 188 cases of chronic type B 180 cases of moderate hepatitis (CHB Ⅱ), severe chronic hepatitis B (CHB